Haglund C - Search Results

1

Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma.

Atula T, Hedström J, Finne P, Leivo I, Markkanen-Leppänen M, Haglund C. Atula T, et al. Among authors: haglund c. Anticancer Res. 2003 May-Jun;23(3C):3051-6. Anticancer Res. 2003. PMID: 12926160

2

Tumour markers and radiological examinations in the follow-up of patients with oral cancer.

Söderholm AL, Lindqvist C, Haglund C. Söderholm AL, et al. Among authors: haglund c. J Craniomaxillofac Surg. 1992 Jul;20(5):211-5. doi: 10.1016/s1010-5182(05)80317-8. J Craniomaxillofac Surg. 1992. PMID: 1357004

3

Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma.

Haglund C, Lindgren J, Roberts PJ, Nordling S. Haglund C, et al. Br J Cancer. 1991 Mar;63(3):386-9. doi: 10.1038/bjc.1991.90. Br J Cancer. 1991. PMID: 1848439 Free PMC article.

4

Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.

Haglund C, Lindgren J, Roberts PJ, Kuusela P, Nordling S. Haglund C, et al. Br J Cancer. 1989 Dec;60(6):845-51. doi: 10.1038/bjc.1989.377. Br J Cancer. 1989. PMID: 2557879 Free PMC article.

5

The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer.

Lundin J, Roberts PJ, Kuusela P, Haglund C. Lundin J, et al. Among authors: haglund c. Br J Cancer. 1994 Mar;69(3):515-9. doi: 10.1038/bjc.1994.93. Br J Cancer. 1994. PMID: 7510116 Free PMC article.

6

Enzyme immunoassay for quantification of tenascin in biologic samples.

Ylätupa S, Mertaniemi P, Haglund C, Partanen P. Ylätupa S, et al. Among authors: haglund c. Clin Biochem. 1995 Jun;28(3):263-8. doi: 10.1016/0009-9120(94)00079-b. Clin Biochem. 1995. PMID: 7554244

7

A prognostic value of CA 19-9 but not of CEA in patients with gastric cancer.

Victorzon M, Haglund C, Lundin J, Roberts PJ. Victorzon M, et al. Among authors: haglund c. Eur J Surg Oncol. 1995 Aug;21(4):379-84. doi: 10.1016/s0748-7983(95)92450-7. Eur J Surg Oncol. 1995. PMID: 7664902

8

Prognostic significance of serum CA 242 in pancreatic cancer. A comparison with CA 19-9.

Lundin J, Roberts PJ, Kuusela P, Haglund C. Lundin J, et al. Among authors: haglund c. Anticancer Res. 1995 Sep-Oct;15(5B):2181-6. Anticancer Res. 1995. PMID: 8572621

9

Sialyl Tn antigen is an independent predictor of outcome in patients with gastric cancer.

Victorzon M, Nordling S, Nilsson O, Roberts PJ, Haglund C. Victorzon M, et al. Among authors: haglund c. Int J Cancer. 1996 Jan 26;65(3):295-300. doi: 10.1002/(SICI)1097-0215(19960126)65:3<295::AID-IJC3>3.0.CO;2-V. Int J Cancer. 1996. PMID: 8575847

10

Prognostic value of immunohistochemical expression of p53 in patients with pancreatic cancer.

Lundin J, Nordling S, von Boguslawsky K, Roberts PJ, Haglund C. Lundin J, et al. Among authors: haglund c. Oncology. 1996 Mar-Apr;53(2):104-11. doi: 10.1159/000227545. Oncology. 1996. PMID: 8604235

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results